glp 1 in the body Glucagon-like peptide-1 (GLP-1) has established effects on glycemic How GLP-1 Medications Work: What

DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks

Clinicians may monitor side effects, hydration, food intake, weight trends, and treatment response

Screening for diabetic kidney disease Early-stage DKD is usually a silent disease, with minimal clinical manifestations until the patient has progressed to an advanced stage of kidney disease

[DOI] [PubMed] [Google Scholar] 81.Schmitt C., Portron A., Jadidi S., Sarkar N., DiMarchi R

State Discretion Because of the federal exclusion allowance, each state makes its own determination about whether Medicaid covers weight loss shots